FENNEC PHARMACEUTICALS INC. (FENC) · INSIDERData sourcesSEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago
Public companyFENNEC PHARMACEUTICALS INC.
FENCCIK 0001211583
Price$9.81
1 year+18.9%
Disclosed transactions44
Buys / sells0 / 1
Max Insider Score36
Connections with evidence6
FENC · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 5 | SSSayad Pierre SargisChief Medical Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | — 168 sh | Oct 31, 2026 | Nov 2, 2026 |
| 9 | ELEvans Terry LChief Commercial Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | — 168 sh | Oct 31, 2026 | Nov 2, 2026 traded Oct 31, 2026 | +2d | SEC Form 4 | |
| 9 | HSHackman Jeffrey S.Director, Chief Executive Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | — 1,159 sh | Oct 31, 2026 | Nov 2, 2026 traded Oct 31, 2026 | +2d | SEC Form 4 | |
| 9 | CMCioffi Christiana MarieChief Strategy Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | — 156 sh | Oct 31, 2026 | Nov 2, 2026 traded Oct 31, 2026 | +2d | SEC Form 4 | |
| 13 | ELEvans Terry LChief Commercial Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | $13K 2,326 sh | Oct 12, 2026 | Oct 13, 2026 traded Oct 12, 2026 | +1d | SEC Form 4 | |
| 13 | SSSayad Pierre SargisChief Medical Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | $21K 3,846 sh | Oct 12, 2026 | Oct 13, 2026 traded Oct 12, 2026 | +1d | SEC Form 4 | |
| 13 | CMCioffi Christiana MarieChief Strategy Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | $22K 3,946 sh | Oct 12, 2026 | Oct 13, 2026 traded Oct 12, 2026 | +1d | SEC Form 4 | |
| 9 | HSHackman Jeffrey S.Director, Chief Executive Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | $12K 2,224 sh | Oct 12, 2026 | Oct 13, 2026 traded Oct 12, 2026 | +1d | SEC Form 4 | |
| 9 | ELEvans Terry LChief Commercial Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | — 168 sh | Sep 30, 2026 | Oct 1, 2026 traded Sep 30, 2026 | +1d | SEC Form 4 | |
| 9 | CMCioffi Christiana MarieChief Strategy Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | — 156 sh | Sep 30, 2026 | Oct 1, 2026 traded Sep 30, 2026 | +1d | SEC Form 4 | |
| 5 | SSSayad Pierre SargisChief Medical Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | — 168 sh | Sep 30, 2026 | Oct 1, 2026 traded Sep 30, 2026 | +1d | SEC Form 4 | |
| 9 | HSHackman Jeffrey S.Director, Chief Executive Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | — 1,159 sh | Sep 30, 2026 | Oct 1, 2026 traded Sep 30, 2026 | +1d | SEC Form 4 | |
| 9 | ELEvans Terry LChief Commercial Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | — 168 sh | Aug 31, 2026 | Aug 31, 2026 traded Aug 31, 2026 | +0d | SEC Form 4 | |
| 9 | HSHackman Jeffrey S.Director, Chief Executive Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | — 1,159 sh | Aug 31, 2026 | Aug 31, 2026 traded Aug 31, 2026 | +0d | SEC Form 4 | |
| 9 | SSSayad Pierre SargisChief Medical Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | — 168 sh | Aug 31, 2026 | Aug 31, 2026 traded Aug 31, 2026 | +0d | SEC Form 4 | |
| 9 | CMCioffi Christiana MarieChief Strategy Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | — 156 sh | Aug 31, 2026 | Aug 31, 2026 traded Aug 31, 2026 | +0d | SEC Form 4 | |
| 36 | SSSayad Pierre SargisChief Medical Officer | FENCFENNEC PHARMACEUTICALS INC. Open-market sale | SELL | $146K 12.0K sh | Aug 31, 2026 | Aug 31, 2026 traded Aug 31, 2026 | +0d | SEC Form 4 | |
| 9 | HSHackman Jeffrey S.Director, Chief Executive Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | — 1,159 sh | Jun 30, 2026 | Jul 1, 2026 traded Jun 30, 2026 | +1d | SEC Form 4 | |
| 9 | ELEvans Terry LChief Commercial Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | — 168 sh | Jun 30, 2026 | Jul 1, 2026 traded Jun 30, 2026 | +1d | SEC Form 4 | |
| 9 | CMCioffi Christiana MarieChief Strategy Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | — 156 sh | Jun 30, 2026 | Jul 1, 2026 traded Jun 30, 2026 | +1d | SEC Form 4 | |
| 9 | SSSayad Pierre SargisChief Medical Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | — 168 sh | Jun 30, 2026 | Jul 1, 2026 traded Jun 30, 2026 | +1d | SEC Form 4 | |
| 16 | | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | $174K 20.0K sh | Jun 10, 2026 | Jun 10, 2026 traded Jun 10, 2026 | +0d | SEC Form 4 | |
| 9 | HSHackman Jeffrey S.Director, Chief Executive Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | — 1,159 sh | May 31, 2026 | Jun 1, 2026 traded May 31, 2026 | +1d | SEC Form 4 | |
| 9 | CMCioffi Christiana MarieChief Strategy Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | — 156 sh | May 31, 2026 | Jun 1, 2026 traded May 31, 2026 | +1d | SEC Form 4 | |
| 9 | ELEvans Terry LChief Commercial Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | — 168 sh | May 31, 2026 | Jun 1, 2026 traded May 31, 2026 | +1d | SEC Form 4 | |
| 9 | SSSayad Pierre SargisChief Medical Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | — 168 sh | May 31, 2026 | Jun 1, 2026 traded May 31, 2026 | +1d | SEC Form 4 | |
| 9 | CMCioffi Christiana MarieChief Strategy Officer | FENCFENNEC PHARMACEUTICALS INC. Option exercise | M | — 155 sh | Apr 30, 2026 | May 1, 2026 traded Apr 30, 2026 | +1d | SEC Form 4 | |
| 9 | HSHackman Jeffrey S.Director, Chief Executive Officer | FENCFENNEC PHARMACEUTICALS INC. Option exercise | M | — 1,159 sh | Apr 30, 2026 | May 1, 2026 traded Apr 30, 2026 | +1d | SEC Form 4 | |
| 9 | SSSayad Pierre SargisChief Medical Officer | FENCFENNEC PHARMACEUTICALS INC. Option exercise | M | — 168 sh | Apr 30, 2026 | May 1, 2026 traded Apr 30, 2026 | +1d | SEC Form 4 | |
| 9 | ELEvans Terry LChief Commercial Officer | FENCFENNEC PHARMACEUTICALS INC. Option exercise | M | — 168 sh | Apr 30, 2026 | May 1, 2026 traded Apr 30, 2026 | +1d | SEC Form 4 | |
| 27 | CMCioffi Christiana MarieChief Strategy Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | $692K 120.0K sh | Mar 31, 2026 | Apr 2, 2026 traded Mar 31, 2026 | +2d | SEC Form 4 | |
| 9 | ELEvans Terry LChief Commercial Officer | FENCFENNEC PHARMACEUTICALS INC. Option exercise | M | — 171 sh | Mar 31, 2026 | Apr 2, 2026 traded Mar 31, 2026 | +2d | SEC Form 4 | |
| 9 | ELEvans Terry LChief Commercial Officer | FENCFENNEC PHARMACEUTICALS INC. Option exercise | M | — 18.5K sh | Mar 31, 2026 | Apr 2, 2026 traded Mar 31, 2026 | +2d | SEC Form 4 | |
| 9 | CMCioffi Christiana MarieChief Strategy Officer | FENCFENNEC PHARMACEUTICALS INC. Option exercise | M | — 158 sh | Mar 31, 2026 | Apr 2, 2026 traded Mar 31, 2026 | +2d | SEC Form 4 | |
| 19 | SSSayad Pierre SargisChief Medical Officer | FENCFENNEC PHARMACEUTICALS INC. Option exercise | M | — 2,052 sh | Mar 28, 2026 | Apr 2, 2026 traded Mar 28, 2026 | +5d | SEC Form 4 | |
| 21 | CMCioffi Christiana MarieChief Strategy Officer | FENCFENNEC PHARMACEUTICALS INC. Option exercise | M | — 17.1K sh | Mar 31, 2026 | Apr 2, 2026 traded Mar 31, 2026 | +2d | SEC Form 4 | |
| 9 | SSSayad Pierre SargisChief Medical Officer | FENCFENNEC PHARMACEUTICALS INC. Option exercise | M | — 171 sh | Mar 31, 2026 | Apr 2, 2026 traded Mar 31, 2026 | +2d | SEC Form 4 | |
| 19 | ELEvans Terry LChief Commercial Officer | FENCFENNEC PHARMACEUTICALS INC. Option exercise | M | — 2,052 sh | Mar 28, 2026 | Apr 2, 2026 traded Mar 28, 2026 | +5d | SEC Form 4 | |
| 9 | SSSayad Pierre SargisChief Medical Officer | FENCFENNEC PHARMACEUTICALS INC. Option exercise | M | — 18.5K sh | Mar 31, 2026 | Apr 2, 2026 traded Mar 31, 2026 | +2d | SEC Form 4 | |
| 27 | SSSayad Pierre SargisChief Medical Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | $692K 120.0K sh | Mar 31, 2026 | Apr 2, 2026 traded Mar 31, 2026 | +2d | SEC Form 4 | |
| 19 | CMCioffi Christiana MarieChief Strategy Officer | FENCFENNEC PHARMACEUTICALS INC. Option exercise | M | — 1,901 sh | Mar 28, 2026 | Apr 2, 2026 traded Mar 28, 2026 | +5d | SEC Form 4 | |
| 27 | ELEvans Terry LChief Commercial Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | $692K 120.0K sh | Mar 31, 2026 | Apr 2, 2026 traded Mar 31, 2026 | +2d | SEC Form 4 | |
| 9 | CMCioffi Christiana MarieChief Strategy Officer | FENCFENNEC PHARMACEUTICALS INC. Option exercise | M | $20K 4,700 sh | Mar 26, 2026 | Mar 26, 2026 traded Mar 26, 2026 | +0d | SEC Form 4 | |
| 9 | CMCioffi Christiana MarieChief Strategy Officer | FENCFENNEC PHARMACEUTICALS INC. Option exercise | M | $20K 4,700 sh | Mar 26, 2026 | Mar 26, 2026 traded Mar 26, 2026 | +0d | SEC Form 4 | |
Chief Medical Officer · Apr 2, 2026